PMID- 18835699 OWN - NLM STAT- MEDLINE DCOM- 20090410 LR - 20191210 IS - 1873-7862 (Electronic) IS - 0924-977X (Linking) VI - 19 IP - 2 DP - 2009 Feb TI - Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. PG - 85-91 LID - 10.1016/j.euroneuro.2008.08.011 [doi] AB - In this study effect of L745,870, a selective D(4) dopamine (DA) receptor blocker, on the pro-cognitive action of intracerebroventricularly (icv) injected angiotensin IV (Ang IV) and des-Phe(6)-Ang IV was examined. Male Wistar rats weighing 180-200 g were used. Both peptides given at the dose of 1 nmol facilitated recall of a passive avoidance (PA) behaviour, improved object recognition (OR) memory, decreased number of errors, increased number of sequential correct entries and shortened time-to-goal in an eight-arm radial maze (RM). In the auxiliary tests performed to control for the participation of unspecific motor (open field, OF) and emotional ('plus' maze, PM) effects of our treatment in the results of memory tests they had either no (OF) or negligible (PM) effects. Intraperitoneal pretreatment of the animals with 1 mg/kg of L745,870 abolished effects of both peptides on PA and OR and slightly diminished those observed in the eight-arm RM. FAU - Braszko, Jan J AU - Braszko JJ AD - Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274 Bialystok, Poland. braszko@umwb.edu.pl LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081005 PL - Netherlands TA - Eur Neuropsychopharmacol JT - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology JID - 9111390 RN - 0 (3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine) RN - 0 (Dopamine Antagonists) RN - 0 (Pyridines) RN - 0 (Pyrroles) RN - 0 (angiotensin IV, des-Phe(6)-) RN - 11128-99-7 (Angiotensin II) RN - 137750-34-6 (Receptors, Dopamine D4) RN - 23025-68-5 (angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-) SB - IM MH - Angiotensin II/administration & dosage/*analogs & derivatives/antagonists & inhibitors/pharmacology MH - Animals MH - Anxiety/psychology MH - Avoidance Learning/drug effects MH - Cognition/*drug effects MH - Data Interpretation, Statistical MH - Dopamine Antagonists/*pharmacology MH - Exploratory Behavior/drug effects MH - Form Perception/drug effects MH - Injections, Intraventricular MH - Male MH - Maze Learning/drug effects MH - Mental Recall/drug effects MH - Motor Activity/drug effects MH - Pyridines/*pharmacology MH - Pyrroles/*pharmacology MH - Rats MH - Rats, Wistar MH - Receptors, Dopamine D4/*antagonists & inhibitors MH - Recognition, Psychology/drug effects EDAT- 2008/10/07 09:00 MHDA- 2009/04/11 09:00 CRDT- 2008/10/07 09:00 PHST- 2008/07/07 00:00 [received] PHST- 2008/08/04 00:00 [revised] PHST- 2008/08/24 00:00 [accepted] PHST- 2008/10/07 09:00 [pubmed] PHST- 2009/04/11 09:00 [medline] PHST- 2008/10/07 09:00 [entrez] AID - S0924-977X(08)00235-6 [pii] AID - 10.1016/j.euroneuro.2008.08.011 [doi] PST - ppublish SO - Eur Neuropsychopharmacol. 2009 Feb;19(2):85-91. doi: 10.1016/j.euroneuro.2008.08.011. Epub 2008 Oct 5.